Table of Contents
Volume 7 | Issue 2
Publication Date: September 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Meeting Highlights | ||
81-86 |
Highlights From: 41st Annual Meeting of American Society of Clinical Oncology, Orlando, FL, 6th International Lung Cancer Congress, Kauai, Hawaii, 11th World Conference on Lung Cancer, Barcelona, Spain G. Kesava Reddy, Preeta Tyagi, Eric Nadler, Vinay K. Jain |
|
Research in Brief | ||
89-91 |
Phase II Data with ZD6474, a Small-Molecule Kinase Inhibitor of Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor, in Previously Treated Advanced Non–Small-Cell Lung Cancer David Lee, Ronald B. Natale, Eric Nadler, Vinay K. Jain |
|
Comprehensive Review | ||
92-99 |
Chemoprevention Strategies for Patients with Lung Cancer in the Context of Screening Nabil F. Saba, Fadlo R. Khuri |
|
Original Contributions | ||
100-106 |
Multivariate Analysis of Survival, Local Control, and Time to Distant Metastases in Patients with Unresectable Non–Small-Cell Lung Carcinoma Treated with 3-Dimensional Conformal Radiation Therapy with or Without Concurrent Chemotherapy Michal J. Wolski, Ajay Bhatnagar, John C. Flickinger, Chandra P. Belani, Suresh Ramalingam, Joel S. Greenberger |
|
107-113 |
Potential for Radiation Therapy Technology Innovations to Permit Dose Escalation for Non–Small-Cell Lung Cancer Rafael R. Mañon, Hazim Jaradat, Rakesh Patel, Tiezhi Zhang, John Fenwick, Wolfgang Tomé, Jack Fowler, Bhudatt Paliwal, Emilie Soisson, Zhilong Yuan, Minesh Mehta |
|
114-120 |
Multicenter Phase II Trial of Carboplatin/Vinorelbine in Elderly Patients with Advanced Non–Small-Cell Lung Cancer—Efficacy and Impact on Quality of Life: Groupe Français de Pneumo-Cancérologie Study 9902 Hervé LeCaer, Jean Yves Delhoume, Pascal André Thomas, Henri Berard, Dominique Paillotin, Jean Renaud Barriere, Céline Gimenez, Alain Vergnenegre, Pierre Muller, Pascal Auquier, Maurice Perol |
|
121-126 |
Continuous-Infusion Vinorelbine for the Treatment of Advanced Non–Small-Cell Lung Cancer: A Phase I/II Study Francisco Carabante-Ocón, Manuel Cobo-Dols, Manuel Benavides-Orgaz, Silvia Gil-Calle, Inmaculada Alés-Díaz, Juan J. Bretón-García, Esther Villar-Chamorro, Alvaro Montesa-Pino, Julia Alcalde-García, Vanesa Gutiérrez-Calderón |
|
127-132 |
Single-Agent Gefitinib in Patients with Untreated Advanced Non–Small-Cell Lung Cancer and Poor Performance Status: A Minnie Pearl Cancer Research Network Phase II Trial David R. Spigel, John D. Hainsworth, Emily R. Burkett, Howard A. Burris, Denise A. Yardley, Melodie Thomas, Suzanne F. Jones, Natalie R. Dickson, Daniel C. Scullin, James E. Bradof, James R. Rubinsak, Joseph E. Brierre, F. Anthony Greco |
|
133-137 |
Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer Wolfgang Schuette, Sylke Nagel, Stefan Juergens, Ines Bork, Bettina Wollschlaeger, Steffen Schaedlich, Thomas Blankenburg |
|
Case Report | ||
138-140 |
Activity of Gefitinib in Central Nervous System Metastases in Patients with Non–Small-Cell Lung Cancer: Two Case Reports and a Review of the Literature Alfonso Gurpide, Jose Luis Perez-Gracia, Jose Maria Lopez-Picazo, Marta Moreno, Jose Luis Zubieta, Salvador Martin-Algarra, Jesus Garcia-Foncillas |
|
Clinical Trials | ||
141 |
Selected Phase I Clinical Trials in Lung Cancer CIG Media Group |
|